The total return over the past 12 months is -94.75% vs. +16.94% for the S&P 500. So far it's up -95.71% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (94.75%) | (41.81%) | (59.51%) | N/A | N/A | N/A |
| Total Return CAGR | (94.75%) | (41.81%) | (59.51%) | N/A | N/A | N/A |
| Revenue CAGR | +32.43% | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Gossamer Bio, Inc. (GOSS)
| Year | Start price | End price | GOSS Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $248.00 | $10.65 | (95.71%) | +14.51% | (110.22%) |
| 2025 | $72.37 | $248.00 | +242.68% | +17.72% | +224.96% |
| 2024 | $73.00 | $72.37 | (0.86%) | +24.89% | (25.75%) |
| 2023 | $173.60 | $73.00 | (57.95%) | +26.19% | (84.14%) |
| 2022 | $904.80 | $173.60 | (80.81%) | (18.17%) | (62.64%) |
| 2021 | $773.60 | $904.80 | +16.96% | +28.74% | (11.78%) |
| 2020 | $1,250.40 | $773.60 | (38.13%) | +18.37% | (56.50%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
